Results 121 to 130 of about 2,705 (182)

A multi-centre, single arm, Phase 3 study to assess the safety and reactogenicity of biological Es Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine in ≥6 months old infants to ≤45 years old adults.

Vaccine: X
Background: Typhoid fever is a serious bacterial infection caused by Salmonella Typhi, with a significant burden in low- and middle-income countries, particularly in Sub-Saharan Africa and South/Southeast Asia.
Subhash Thuluva, Ramesh V. Matur, Subbareddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Chirag Dhar, Raju Esanakarra, Savita Verma, Manish Narang, Madhukar Pandey   +9 more
doaj   +1 more source

Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling studyResearch in context

The Lancet Regional Health - Southeast Asia
Summary: Background: India is one of the countries with a high typhoid fever burden. In 2022, the National Technical Advisory Group on Immunisation recommended including the typhoid conjugate vaccine (TCV) in the Universal Immunisation Programme.
Vijayalaxmi V. Mogasale, Jacob John, Nikhil Sahai, Arindam Ray, Habib Hasan Farooqui, Vittal Mogasale, Bhim Gopal Dhoubhadel, W. John Edmunds, Andrew Clark, Kaja Abbas   +9 more
doaj   +1 more source

Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe [PDF]

The Lancet Infectious Diseases, 2019
Olaru, Ioana D, Mtapuri-Zinyowera, Sekesai, Feasey, Nicholas, Ferrand, Rashida A, Kranzer, Katharina   +4 more
openaire   +4 more sources

On the Ground in Malawi—First Typhoid Conjugate Vaccine Study in Africa [PDF]

The American Journal of Tropical Medicine and Hygiene, 2019
Patel, P., Patel, P., Meiring, J.E., Misiri, T., Mwakiseghile, F., Gordon, M.A.   +5 more
openaire   +3 more sources

Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India. [PDF]

Clin Infect Dis, 2023
Hoffman SA, LeBoa C, Date K, Haldar P, Harvey P, Shimpi R, An Q, Zhang C, Jayaprasad N, Horng L, Fagerli K, Borhade P, Daruwalla S, Dharmapalan D, Gavhane J, Joshi S, Rai R, Rathod V, Shetty K, Warrier DS, Yadav S, Chakraborty D, Bahl S, Katkar A, Kunwar A, Yewale V, Andrews JR, Bhatnagar P, Dutta S, Luby SP.   +29 more
europepmc   +1 more source

A trial of a typhoid conjugate vaccine in children in Malawi [PDF]

The Lancet Microbe, 2021
openaire   +2 more sources

The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study. [PDF]

Lancet Glob Health, 2023
Olaru ID, Chingono RMS, Bottomley C, Kandiye FR, Mhino F, Nyamayaro CA, Manyau S, Vere M, Chitando P, Chonzi P, Darton TC, Dixon J, Kranzer K.   +12 more
europepmc   +1 more source

Typhoid conjugate vaccines: a step towards typhoid control

The Lancet Global Health
Shakya, M, Pollard, AJ
openaire   +2 more sources

Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction - Worldwide, 2018-2022. [PDF]

MMWR Morb Mortal Wkly Rep, 2023
Hancuh M, Walldorf J, Minta AA, Tevi-Benissan C, Christian KA, Nedelec Y, Heitzinger K, Mikoleit M, Tiffany A, Bentsi-Enchill AD, Breakwell L.   +10 more
europepmc   +1 more source

Genomic analysis of <i>Salmonella</i> Typhi from a typhoid conjugate vaccine trial. [PDF]

Microb Genom
Kutambe BM, Patel PD, Chizani K, Silungwe N, Kukacha C, Carey ME, Meiring JE, Laurens MB, Gordon MA, Ashton PM.   +9 more
europepmc   +1 more source